Vanguard Group Inc Bio Rad Laboratories, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,793,537 shares of BIO stock, worth $562 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,793,537
Previous 1,846,543 2.87%
Holding current value
$562 Million
Previous $446 Million 12.85%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$241.95 - $303.82 $12.8 Million - $16.1 Million
-53,006 Reduced 2.87%
1,793,537 $503 Million
Q2 2025

Aug 11, 2025
SELL
$216.56 - $256.68 $14.2 Million - $16.8 Million
-65,614 Reduced 3.43%
1,846,543 $446 Million
Q1 2025

May 09, 2025
SELL
$243.0 - $367.0 $1.86 Million - $2.81 Million
-7,651 Reduced 0.4%
1,912,157 $466 Million
Q4 2024

Feb 11, 2025
BUY
$313.15 - $374.28 $3.81 Million - $4.55 Million
12,168 Added 0.64%
1,919,808 $631 Million
Q3 2024

Nov 13, 2024
SELL
$263.97 - $344.64 $123 Million - $161 Million
-466,867 Reduced 19.66%
1,907,640 $638 Million
Q2 2024

Aug 13, 2024
SELL
$268.26 - $339.48 $12.6 Million - $15.9 Million
-46,827 Reduced 1.93%
2,374,507 $649 Million
Q1 2024

May 10, 2024
BUY
$304.11 - $351.99 $9.56 Million - $11.1 Million
31,445 Added 1.32%
2,421,334 $837 Million
Q4 2023

Feb 14, 2024
BUY
$269.37 - $365.04 $12.4 Million - $16.8 Million
46,119 Added 1.97%
2,389,889 $772 Million
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $18 Million - $21.7 Million
-51,443 Reduced 2.15%
2,343,770 $840 Million
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $759,602 - $1.03 Million
-2,113 Reduced 0.09%
2,395,213 $908 Million
Q1 2023

May 15, 2023
BUY
$418.69 - $503.0 $2.47 Million - $2.96 Million
5,890 Added 0.25%
2,397,326 $1.15 Billion
Q4 2022

Feb 10, 2023
BUY
$351.71 - $456.01 $14 Million - $18.2 Million
39,908 Added 1.7%
2,391,436 $1.01 Billion
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $1 Million - $1.37 Million
2,428 Added 0.1%
2,351,528 $981 Million
Q2 2022

Aug 12, 2022
BUY
$463.67 - $597.16 $14.4 Million - $18.6 Million
31,159 Added 1.34%
2,349,100 $1.16 Billion
Q1 2022

May 13, 2022
BUY
$524.57 - $735.42 $16 Million - $22.4 Million
30,476 Added 1.33%
2,317,941 $1.31 Billion
Q4 2021

Feb 14, 2022
BUY
$708.84 - $794.68 $12.9 Million - $14.5 Million
18,200 Added 0.8%
2,287,465 $1.73 Billion
Q3 2021

Nov 12, 2021
SELL
$657.71 - $825.77 $8.18 Million - $10.3 Million
-12,433 Reduced 0.54%
2,269,265 $1.69 Billion
Q2 2021

Aug 13, 2021
BUY
$576.64 - $649.04 $1.32 Billion - $1.48 Billion
2,281,698 New
2,281,698 $1.47 Billion

Others Institutions Holding BIO

# of Institutions
434
Shares Held
19.4M
Call Options Held
6K
Put Options Held
3.3K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.71B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email